Cargando…
Response to “Should estrogen be used in the co-treatment of COVID-19 patients?”
Autores principales: | Cano, Antonio, Ramírez, Isabel, De la Viuda, Esther, Baquedano, Laura, Coronado, Pluvio, Llaneza, Plácido, Otero, Borja, Sánchez, Sonia, Cancelo, Mª Jesús, Páramo, José Antonio, Mendoza, Nicolás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833207/ https://www.ncbi.nlm.nih.gov/pubmed/32747134 http://dx.doi.org/10.1016/j.maturitas.2020.06.014 |
Ejemplares similares
-
The thromboembolic risk in covid-19 women under hormonal treatment group
por: Ramírez, Isabel, et al.
Publicado: (2020) -
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia
por: Ramírez, Isabel, et al.
Publicado: (2020) -
Health-related quality of life and resilience in peri- and postmenopausal women during Covid-19 confinement
por: Coronado, Pluvio J., et al.
Publicado: (2021) -
Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review
por: Fiol, Gabriel, et al.
Publicado: (2023) -
Survival Analysis in Endometrial Carcinomas by Type of Surgical Approach: A Matched-Pair Study
por: Coronado, Pluvio J., et al.
Publicado: (2022)